Enveric Biosciences, Inc. (ENVB): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$14.10M
Year ended 2023-12-31
2021-12-31: -$11.65M2022-12-31: -$17.73M2023-12-31: -$14.10M-$14.10M
2021-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$14.10Mn/m2025-03-28, From 2023-01-01
2022-12-31-$17.73Mn/m2024-03-26, From 2022-01-01
2021-12-31-$11.65Mn/a2023-06-09, From 2021-01-01